Literature DB >> 23927036

Post-translational modification by cysteine protects Cu/Zn-superoxide dismutase from oxidative damage.

Jared R Auclair1, Joshua L Johnson, Qian Liu, Joseph P Salisbury, Melissa S Rotunno, Gregory A Petsko, Dagmar Ringe, Robert H Brown, Daryl A Bosco, Jeffrey N Agar.   

Abstract

Reactive oxygen species (ROS) are cytotoxic. To remove ROS, cells have developed ROS-specific defense mechanisms, including the enzyme Cu/Zn superoxide dismutase (SOD1), which catalyzes the disproportionation of superoxide anions into molecular oxygen and hydrogen peroxide. Although hydrogen peroxide is less reactive than superoxide, it is still capable of oxidizing, unfolding, and inactivating SOD1, at least in vitro. To explore the relevance of post-translational modification (PTM) of SOD1, including peroxide-related modifications, SOD1 was purified from postmortem human nervous tissue. As much as half of all purified SOD1 protein contained non-native post-translational modifications (PTMs), the most prevalent modifications being cysteinylation and peroxide-related oxidations. Many PTMs targeted a single reactive SOD1 cysteine, Cys111. An intriguing observation was that unlike native SOD1, cysteinylated SOD1 was not oxidized. To further characterize how cysteinylation may protect SOD1 from oxidation, cysteine-modified SOD1 was prepared in vitro and exposed to peroxide. Cysteinylation conferred nearly complete protection from peroxide-induced oxidation of SOD1. Moreover, SOD1 that has been cysteinylated and peroxide oxidized in vitro comprised a set of PTMs that bear a striking resemblance to the myriad of PTMs observed in SOD1 purified from human tissue.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23927036      PMCID: PMC3859700          DOI: 10.1021/bi4006122

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  36 in total

1.  Strategies for stabilizing superoxide dismutase (SOD1), the protein destabilized in the most common form of familial amyotrophic lateral sclerosis.

Authors:  Jared R Auclair; Kristin J Boggio; Gregory A Petsko; Dagmar Ringe; Jeffrey N Agar
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

2.  Amino acid abnormalities in cerebrospinal fluid of patients with parkinsonism and extrapyramidal disorders.

Authors:  J P Lakke; A W Teelken
Journal:  Neurology       Date:  1976-05       Impact factor: 9.910

3.  Reduced and oxidized glutathione in human and monkey brain.

Authors:  A Slivka; M B Spina; G Cohen
Journal:  Neurosci Lett       Date:  1987-02-10       Impact factor: 3.046

4.  Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases.

Authors:  Joungil Choi; Howard D Rees; Susan T Weintraub; Allan I Levey; Lih-Shen Chin; Lian Li
Journal:  J Biol Chem       Date:  2005-01-19       Impact factor: 5.157

5.  Characterization of cysteinylation of pharmaceutical-grade human serum albumin by electrospray ionization mass spectrometry and low-energy collision-induced dissociation tandem mass spectrometry.

Authors:  Martina Kleinova; Omar Belgacem; Katharina Pock; Andreas Rizzi; Andrea Buchacher; Günter Allmaier
Journal:  Rapid Commun Mass Spectrom       Date:  2005       Impact factor: 2.419

6.  Tryptophan 32 potentiates aggregation and cytotoxicity of a copper/zinc superoxide dismutase mutant associated with familial amyotrophic lateral sclerosis.

Authors:  David M Taylor; Bernard F Gibbs; Edor Kabashi; Sandra Minotti; Heather D Durham; Jeffrey N Agar
Journal:  J Biol Chem       Date:  2007-03-27       Impact factor: 5.157

7.  Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis.

Authors:  Lawrence J Hayward; Jorge A Rodriguez; Ji W Kim; Ashutosh Tiwari; Joy J Goto; Diane E Cabelli; Joan Selverstone Valentine; Robert H Brown
Journal:  J Biol Chem       Date:  2002-02-19       Impact factor: 5.157

8.  The standard redox potential of cysteine-cystine from the thiol-disulphide exchange reaction with glutathione and lipoic acid.

Authors:  P C Jocelyn
Journal:  Eur J Biochem       Date:  1967-10

9.  Histochemical evaluation of glutathione in brain.

Authors:  A Slivka; C Mytilineou; G Cohen
Journal:  Brain Res       Date:  1987-04-21       Impact factor: 3.252

10.  Subunit-destabilizing mutations in Drosophila copper/zinc superoxide dismutase: neuropathology and a model of dimer dysequilibrium.

Authors:  J P Phillips; J A Tainer; E D Getzoff; G L Boulianne; K Kirby; A J Hilliker
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

View more
  13 in total

Review 1.  From structure to redox: The diverse functional roles of disulfides and implications in disease.

Authors:  Tyler J Bechtel; Eranthie Weerapana
Journal:  Proteomics       Date:  2017-03       Impact factor: 3.984

2.  Artifacts to avoid while taking advantage of top-down mass spectrometry based detection of protein S-thiolation.

Authors:  Jared R Auclair; Joseph P Salisbury; Joshua L Johnson; Gregory A Petsko; Dagmar Ringe; Daryl A Bosco; Nathalie Y R Agar; Sandro Santagata; Heather D Durham; Jeffrey N Agar
Journal:  Proteomics       Date:  2014-04-17       Impact factor: 3.984

Review 3.  Top-down proteomics in health and disease: challenges and opportunities.

Authors:  Zachery R Gregorich; Ying Ge
Journal:  Proteomics       Date:  2014-05       Impact factor: 3.984

4.  Parsing disease-relevant protein modifications from epiphenomena: perspective on the structural basis of SOD1-mediated ALS.

Authors:  N D Schmitt; J N Agar
Journal:  J Mass Spectrom       Date:  2017-07       Impact factor: 1.982

5.  Antioxidant Status of Rat Liver Mitochondria under Conditions of Moderate Hypothermia of Different Duration.

Authors:  S I Khizrieva; R A Khalilov; A M Dzhafarova; V R Abdullaev
Journal:  Bull Exp Biol Med       Date:  2022-01-10       Impact factor: 0.804

6.  Structural consequences of cysteinylation of Cu/Zn-superoxide dismutase.

Authors:  Jared R Auclair; Heather R Brodkin; J Alejandro D'Aquino; Gregory A Petsko; Dagmar Ringe; Jeffrey N Agar
Journal:  Biochemistry       Date:  2013-08-26       Impact factor: 3.162

7.  Identification of a misfolded region in superoxide dismutase 1 that is exposed in amyotrophic lateral sclerosis.

Authors:  Melissa S Rotunno; Jared R Auclair; Stephanie Maniatis; Scott A Shaffer; Jeffrey Agar; Daryl A Bosco
Journal:  J Biol Chem       Date:  2014-08-27       Impact factor: 5.157

8.  Post-translational modifications of transthyretin affect the triiodonine-binding potential.

Authors:  Andrea Henze; Thomas Homann; Mustafa Serteser; Ozge Can; Ozlem Sezgin; Abdurrahman Coskun; Ibrahim Unsal; Florian J Schweigert; Aysel Ozpinar
Journal:  J Cell Mol Med       Date:  2014-10-14       Impact factor: 5.310

Review 9.  An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis.

Authors:  Melissa S Rotunno; Daryl A Bosco
Journal:  Front Cell Neurosci       Date:  2013-12-16       Impact factor: 5.505

10.  L-cysteine supplementation upregulates glutathione (GSH) and vitamin D binding protein (VDBP) in hepatocytes cultured in high glucose and in vivo in liver, and increases blood levels of GSH, VDBP, and 25-hydroxy-vitamin D in Zucker diabetic fatty rats.

Authors:  Sushil K Jain; Preeti Kanikarla-Marie; Cassandra Warden; David Micinski
Journal:  Mol Nutr Food Res       Date:  2016-04-14       Impact factor: 5.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.